Showing posts with label The Future Is Now. Show all posts
Showing posts with label The Future Is Now. Show all posts

Friday, July 15, 2016

EP 023 Kevin Kelly

Kevin Kelly spends a lot of time thinking about the future. He once spent six months imagining that he only had six months to live (and keeps a timer on his own life expectancy), and co-founded the Long Now foundation, built around the idea of a 10,000 year clock to promote very long term thinking. His current book, The Inevitable: Understanding the Twelve Technological Forces that will Shape Our Future, deals with the future that is happening now, the ongoing future, the one William Gibson says is already here, just not evenly distributed yet. He is the co-founder and current Chief Maverick of Wired, and is a prolific writer, publisher, photographer and founder of group projects, including the Cool Tools book and website, The Silver Cord, a crowdfunded graphic novel about angels, and the Quantified Self meetups.

Today, we talk about how to think about the future, why people choose personalization over privacy, what it might mean to look through someone else's eyes for a day, and why the artificial intelligences in your future won't be what you expect.


Thursday, June 04, 2015

The Future Is Now, Vol. LXXXVIII: Researchers Grow Rat Limb In A Jar


A team from Massachusetts General Hospital under Harald Ott regrew rat and primate forelimbs ex vivo, and then transplanted it back into a host animal. They did it by removing all of the cells from an amputated arm, reseeding it with appropriate cell types for the various tissues in a bioreactor atop the existing extracellular scaffolding, and then reattaching it.

This is not quite as impressive as growing it up from nothing, but it represents a substantial step forward from existing technology which is capable of doing single or dual cell type tissue growth. This is multiple tissue, structured repopulation and regrowth of tissue. That's huge.

Wednesday, January 30, 2013

The Future Is Now, Vol. LXXXVII, Good News Edition

In Mali, it appears that many or most of the rare manuscripts had been spirited away from the Ahmed Baba Institute by local Malians before retreating Islamists burned the library down.

In America, quadruple amputee and veteran Brendan Marocco received a double arm transplant that may enable him to have fine motor control over his new limbs. Awesome.

Saturday, February 18, 2012

The Future Is Now, Vol. LXXXVI: Your Pocket Gene Sequencer

For $900, you can buy Nanopore's USB-stick-sized gene sequencer, or for somewhat more you can buy an "array of desktop sized" machines that can sequence your genome in 15 minutes. Fun for the whole family.

Friday, January 13, 2012

The Future is Now, Vol. LXXXV: The Skin Cell Gun

Jörg Gerlach's skin cell gun is supposed to be able to replace burned skin within four days. One of the most amazing cell culture applications I've ever seen:

Monday, December 27, 2010

The Future Is Now, Vol. LXXXIV: Village Greens

The Peace Corps reports on the growth of green power generation among remote villages, including solar, water, biofuel and wind generators that power hyperefficient lighting and other low-wattage, high-value appliances.

Friday, November 05, 2010

The Future Is Now, Vol. LXXXIII: Military Medical Technology

Wired Danger Room has a roundup of the cutting-edge projects currently underway. Two big overlapping areas here: prosthetics and stem cells, with some lasers thrown in for good measure. Because, who doesn't need a stem-cell generated prosthetic with a frikkin' laser beam strapped to it?

Wednesday, August 11, 2010

I Heard You Liked Cyberpunk...

...so I put a little cyberpunk on your cyberpunk. We are reminded again that we're all living in one of William Gibson's fever dreams. There's a reason that all of those guys are writing about the present now--it's because we're living in the future they wrote about, or maybe all of the futures simultaneously.

Thursday, May 20, 2010

The Future Is Now, Vol. LXXXI: Synthetic Life

Craig Venter and friends just announced the continuous replication of a lifeform with a completely synthetic genome. In short, new life. This is a big one.

Caveat: existing cells are still required to house the novel genome.

For now, Igor, for now...

Tuesday, April 27, 2010

The Future Is Now, Vol LXXX: Laser Mass Spec Imaging

This is some really exciting stuff: take a confocal laser and scan a tissue slice, blasting off samples of its constituent molecules, and then shove those samples through a mass spec. Generate a fully 2D realized image of the chemical peaks coming off the sample, process the image in false color, based on whatever post-hoc data you'd like to suggest.

Crazy hot.

Saturday, March 27, 2010

The Future Is Now, Vol LXXIX: RNA Origami

John Rinn studies large intervening non coding RNA, transcribed from the "junk" part of the genome in between the protein-coding segments. He says that among other things, it manages the conformational structure of the DNA, determining the differentiation of cells. He also skateboards.
What are you reading now?

Good to Great by Jim Collins. I was hooked by the sentence: “The enemy of great is good.” Other than that, perhaps most of my nonscientific reading occurs perusing snowboarding and skateboarding magazines with a cup of coffee at a bookstore. The way these athletes push boundaries inspires me scientifically.

Before finding science I was actually focused on a snowboarding and skateboarding career, and academics took a backseat to those loves at that time. But several severe injuries, an influential book, and a consequent shift in perspective changed that path dramatically. I now see risk-taking science as similar to skating or boarding. “Go big, or get hurt,” as we say. Practicing tricks over and over is like an experiment. Moreover, connecting a series of tricks down a mountain or while skateboarding for a beautiful run is a metaphor to me for connecting various lines of experimental results.

Tuesday, December 22, 2009

The Future Is Now, Vol LXXVIII: Waking Up the Stem Cells

Amy Wagers wants to isolate the wound healing factors that are present in young animals that promote rapid healing and recovery.
Recently she has discovered a “partial pathway,” previously undescribed in the blood system, that is involved in the process of repair. “The reason we thought the factor that awakens muscle stem cells might be in the blood,” she explains, “is that organ systems decline globally with age, which implies that any signal has to reach many different locations.” A good place to look for a universal signal such as that, she reasoned, is in the blood.

In fact, her work has already shown that exposing an old animal to the blood of a young animal restores function to progenitor cells in a variety of tissues, not only in skeletal muscle. She is now collaborating with other Harvard laboratories to study such effects in the pancreas, liver, brain, and heart. “This might be a more broadly applicable mechanism,” she says, “an inroad for discovering pathways that can enhance repair activity.” In some cases, Wagers thinks, induced repair mechanisms that fail with age might overlap with genetic disorders, so that studying these pathways could advance research on cures for certain diseases. At the very least, she suspects that the “kinds of molecules we discover that enhance endogenous repair activity” could someday play an important role in readying tissues for cell therapy, once that field is mature. Adds Melton, “This has gotten us thinking more about not just fixing the human body when it is broken, but about how to harness the natural activity of stem cells for homeostatic repair to keep us healthy. We’re not there yet, but I think that is where we are headed.”


(via 3QD)

Friday, November 20, 2009

The Future Is Now, Vol LXXVII: Cortical Simulation Advances


Using an IBM Blue Gene supercomputer, scientists in California simulated a cortex with approximately 6% of human complexity, "that exceed[s] the complexity of the cat cortex".
Not representing a full cat cortex, as has been described elsewhere--a subtle but important distinction. It's going to be one thing to do a large scale simulation with an appropriate number of neurons and connections, and quite another level of difficulty to do a specific type of brain. Still, this is moving ahead nicely.
Update: Markham says, "it's a scam". Just a big neural network, not a simulated brain.

Thursday, July 23, 2009

The Future is Now, Vol LXXVI

Researchers in Shanghai have converted mouse fibroblasts (skin cells) into pluripotent stem cells, and then used the stem cells to clone fertile offspring.

"One line can generate such competent mice that the longest living one we have is nine months," Zeng told Reuters.

"It has generated now more than 100 of second-generation (mice) and more than 100 third-generation (mice). It really demonstrates how fertile and strong the system is."

Tuesday, June 30, 2009

The Future Is Now, LXXV: Geoengineering: Cheap, Easy, Dangerous

For $100B, you can pump sulfur dioxide into the atmosphere to counteract greenhouse gases, turning the sky red in the process. Only problem is, no one knows for sure what will happen if you do, or what happpens when you stop.

T he scariest thing about geo-engineering, as it happens, is also the thing that makes it such a game-changer in the global-warming debate: it’s incredibly cheap. Many scientists, in fact, prefer not to mention just how cheap it is. Nearly everyone I spoke to agreed that the worst-case scenario would be the rise of what David Victor, a Stanford law professor, calls a “Greenfinger”—a rich madman, as obsessed with the environment as James Bond’s nemesis Auric Goldfinger was with gold. There are now 38 people in the world with $10 billion or more in private assets, according to the latest Forbes list; theoretically, one of these people could reverse climate change all alone. “I don’t think we really want to empower the Richard Bransons of the world to try solutions like this,” says Jay Michaelson, an environmental-law expert, who predicted many of these debates 10 years ago.

Even if Richard Branson behaves, a single rogue nation could have the resources to change the climate. Most of Bangladesh’s population lives in low-elevation coastal zones that would wash away if sea levels rose. For a fraction of its GDP, Bangladesh could refreeze the ice caps using sulfur aerosols (though, in a typical trade-off, this might affect its monsoons). If refreezing them would save the lives of millions of Bangladeshis, who could blame their government for acting? Such a scenario is unlikely; most countries would hesitate to violate international law and become a pariah. But it illustrates the political and regulatory complications that large-scale climate-changing schemes would trigger.

Friday, June 05, 2009

The Future Is Now, LXXIV: Stem Cells for Corneas



Researchers at the University of New South Wales cultured stem cells from patients' healthy eyes onto contact lenses which were then placed into their diseased eyes, resulting in improved corneal condition within 10 to 14 days.

Friday, May 08, 2009

The Future Is Now Vol. LXXIII: Brains!

Scientists found a site for intention located in the parietal cortex, using brain stimulation techniques. They contrast the "desire to move" caused by stimulation of this area with the "unconscious movement" caused by stimulation of frontal premotor areas. (via Warren Ellis)

In other news, other scientists found a gamma secretase related drug that breaks up amyloid clots in Alzheimer's patients. Other preclinical methods include a histone deacetylase manipulator that helps reconfigure DNA to enhance the recovery and disposal mechanisms in Alzheimer's brains.

Wednesday, April 22, 2009

The Future Is Now, Vol. LXXII: Blue Brain

The Brain Mind Institute is attempting to simulate the brain down to the molecular level, starting with a single cortical stack:

The Blue Brain project launched in 2005 as the most ambitious brain simulation effort ever undertaken.

While many computer simulations have attempted to code in "brain-like" computation or to mimic parts of the nervous systems and brains of a variety of animals, the Blue Brain project was conceived to reverse-engineer mammal brains from real laboratory data and to build up a computer model down to the level of the molecules that make them up.

The first phase of the project is now complete; researchers have modeled the neocortical column - a unit of the mammalian brain known as the neocortex which is responsible for higher brain functions and thought.

"The thing about the neocortical column is that you can think of it as an isolated processor. It is very much the same from mouse to man - it gets a bit larger a bit wider in humans, but the circuit diagram is very similar," Henry Markram, leader of the Blue Brain project and founder of the Brain Mind Institute in Switzerland, told BBC News.

He added that, when evolution discovered this "mammalian secret", it duplicated it many many times and then "used it as it needed more and more functionality".

Wednesday, March 25, 2009

The Future Is Now Vol. LXXI: Growing Muscles

Wired Magazine reports on the success of phase 1 of Worchester Polytechnic Institute's DARPA backed program to regenerate soldier's limbs:

The first phase of the Pentagon's plan to regrow soldiers' limbs is complete; scientists managed to turn human skin into the equivalent of a blastema — a mass of undifferentiated cells that can develop into new body parts. Now, researchers are on to phase two: turning that cellular glop into a square inch of honest-to-goodness muscle tissue.

...Step one will be trying to get those undifferentiated cells to turn into something like muscle cells. That means making sure the cells have myosin and actin — two proteins that are key to forming the cellular cytoskeleton, and to building muscle filaments. Then, Page and his team will try to get those cells to form around a scaffolding of tiny threads, made of biomaterial. Exactly what will be in thread, Page isn't quite sure — maybe collagens, maybe fibrinogens. It's one of many mysteries to unravel, as his team tries to grow body parts from scratch.
Match a successful muscle growth program with existing bone printing technology and in-progess connective tissue advances and you've just got to figure out how to wire the nerves and get the plumbing, I mean, vasculature in place. It's a hell of an effort, but boy, is there a big payoff.

Wednesday, February 04, 2009

The Future Is Now Vol. LXX: Cheaper Nucleotides & Secondary Immune Systems


Rob Carlson notes the falling prices for gene synthesis and sequencing, at about $0.50 and $0.001, respectively, in 2008. Anders ponders whether we'll find the knee for these cost curves, as we did with Moore's Law.
In other news, researchers from the University of Pennsylvania are starting a clinical trial to produce an AIDS-resistant subset of immune cells:



Since the discovery that a small portion of people who are exposed to HIV do not get infected, scientists have been working to discover the secret to those people's resistance and how to make others resistant as well.

It turns out that most people have a gene called CCR5, which makes them vulnerable to HIV infections. The naturally resistant people have mutant CCR5 genes that inhibit HIV.

Previously, scientists found that by cutting the CCR5 gene out of white blood cells involved in the immune response known as T-cells, they could protect a tube full of human cells from the virus. The gene editing technique relies on proteins called zinc finger nucleases that can delete any gene from a living cell.

In theory, zinc finger nucleases could give that immunity to anyone.

The procedure is simple: Take some healthy T-cells out of an HIV patient, clip out their CCR5 genes, grow more of these clipped T-cells in a dish, and then put them back in the patient.


This is the next step in the development of customized secondary immune systems, capable of dealing with specific pathogens, enhancing wound healing, or replacement for immunocompromised individuals. The outstanding technical questions include:

  • Will the immune cells be sufficiently active once reintroduced to the host?
  • Can the secondary immune system be scaled up quickly enough in every case?
  • Could pre-prepared, 3rd party stem cell derived immune systems be deployed?
  • If so, how could autoimmunity or other adverse host reactions be avoided?

If all of that can be worked out, this would become a hugely important medical technique in coming decades. I look forward to watching this story develop.